Back to the main directory
EarningsReview / Equity
- An uninspiring quarter by BNP Paribas Exane
- PANW: Solid F1Q Beat & Raise Driven By Product; Reiterate Outperform by Raymond James
- Flex LNG (Buy, TP: NOK23.60) - Not cooling down by DnB Markets
- A bid, innovation and acquisitions by DnB Markets
- Black Thursday by BNP Paribas Exane
- Thought Provoking Charts of the Month by BNP Paribas Exane
- ATD.B: Healthy Earnings Beat; Raising Estimates and Price Target by Raymond James
- AVAV: Little Turbulence as AVAV Soars Pass F1H19, but Expectations Were High by Raymond James
- TCO: Lowering 2019/2020 Estimates; Maintaining Market Perform Rating by Raymond James
- The weekly navigator by DnB Markets
- Nordic Nanovector (Buy, TP: NOK110.00) - Updated LYMRIT-37-01 data by DnB Markets
- Weekly ESG Number 529 (26 – 30 November 2018) by Oddo BHF
- They''ve got this covered by BNP Paribas Exane
- Conference Feedback - A mood clouded by uncertainties by BNP Paribas Exane
- So the last shall be first by BNP Paribas Exane
- Roadshow feedback by BNP Paribas Exane
- Infra penny, infra pound by BNP Paribas Exane
- Adjusting estimates, valuation post sector correction by BNP Paribas Exane
- Resetting post Apple resolution by BNP Paribas Exane
- Resetting estimates post sector correction, CMD by BNP Paribas Exane
- Oncopeptides (Buy, TP: SEK247.00) - HORIZON update at ASH 2018 by DnB Markets
- CMD: Solid topline outlook offset by capex, RandD needs by BNP Paribas Exane
- CGG (Buy, TP: EUR2.00) - Time to revisit after recent drop by DnB Markets
- 100 questions into the Capital Markets Day by BNP Paribas Exane
- Espresso | Colruyt | Reduce | Ahead of half-year results by Kepler Cheuvreux